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Partially Protected Left Main Stenting in 
a Patient with Complete Obstruction of 
Left Internal Mammary Graft
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A B S T R A C T
We present a 59-year-old patient with a previous history of coronary artery bypass 
grafting (CABG) for left main and mid-left anterior descending (LAD) coronary 
artery disease with the use of left internal mammary artery (LIMA) and a radial 
graft six years ago. He performed a treadmill stress test which documented extensive 
ischemia in V2-V6 precordial leads with significant blood pressure drop. Coronary 
angiogram revealed complete obstruction of the LIMA and patent radial graft. The 
patient preferred percutaneous intervention (PCI) to CABG as a revascularization 
strategy. The procedure was guided by intravascular ultrasound. We implanted two 
drug eluting stents, the first one in the mid-LAD overlapped with the second one 
which covered the vessel up to the ostium of the left main. Significant plaque shift to 
the ostium of the left circumflex was treated with a kissing balloon technique.
C A S E  P R E S E N T A T I O N
A 59 years old man, ex-smoker, with a history of hypertension, hyperlipidemia, and 
coronary artery bypass grafting (CABG), presented in our department for a treadmill 
stress test. Six years earlier, he had been diagnosed with left main coronary artery 
disease and a concomitant 70% stenosis in the mid-left anterior descending (LAD) 
coronary artery and was treated with CABG with the use of left internal mammary graft 
(LIMA) to the LAD and a radial artery graft to the obtuse marginal branch of the left 
circumflex. A dobutamine stress echocardiography test was negative for myocardial 
ischemia three years ago. The patient had his blood pressure well controlled after a 
recent modification of his antihypertensive medication. He was recently advised to 
have a treadmill stress test to assess blood pressure response during exercise.
He performed a full treadmill exercise test up to the 4th stage of the Bruce protocol 
without developing any symptoms but with a hypertensive response since his arterial 
blood pressure was measured 165/110mmHg at that point. However, at 10 min into the 
test he started complaining of dizziness which necessitated the discontinuation of the 
test. His blood pressure was measured at 97/60 mmHg and he developed marked ST 
segment depression on leads V2-V6 ECG (Fig. 1) without any angina. He was started 
on fluids intravenously, but 11 minutes later his blood pressure was remaining low 
(70/50 mmHg) despite the complete resolution of the ECG changes. Blood pressure 
was restored to normal 30 minutes later. Based on this test result, he was advised to 
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ABBREVIATIONS
CABG= coronary artery bypass grafting
IVUS= intravascular ultrasound
LAD= left anterior descending (coronary 
artery)
LCx= left circumflex (coronary artery)
LIMA= left internal mammary artery
LMCA= left main coronary artery
PCI= percutaneous coronary intervention
SVG= saphenous vein graft
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have a coronary angiogram on an urgent basis.
C O R O N A R Y  A N G I O G R A P H Y
The patient agreed and he was taken to the cath lab within 
the next one hour. The coronary angiogram showed distal left 
main stenosis of 60-70% extending in the proximal LAD, a 
70% stenosis at the mid LAD (small vessel with vessel diam-
eter 2 mm as measured by quantitative coronary angiography) 
(Fig. 2A), a 50% stenosis at the proximal segment of the left 
circumflex (LCx) (Fig. 2B), a patent radial graft anastomosed 
at the obtuse marginal (Fig. 2D), and complete absence of the 
LIMA (even after a contrast infusion with a pigtail catheter 
in the left subclavian artery) (Fig. 2C). We had a lot of dif-
ficulties to accomplish the procedure because of repeated 
“ventricularisation” of blood pressure when the catheter was 
inserted into the left main stem. Since left main and LAD 
seemed to be small in diameter, we performed an intravascular 
ultrasound (IVUS) run (Atlantis, Boston Scientific 40 MHz) 
using a motorized pullback system (0.5 mm/sec) in the LAD 
in order to determine the real size of the LAD and the left 
main and the real degree of stenosis. We defined the vessel 
size as the distance from media to media. At the mid part of 
LAD, the vessel was almost 3 mm in diameter and 3-3.5 mm 
in its proximal part (Fig. 3A and 3B, respectively). The most 
stenosed area lumen was measured at 2.4 cm2 in the mid part 
with encroachment of the IVUS catheter and 3.3 cm2 at the 
ostium (Fig. 3A and 3B, respectively). Left main was almost 
4-4.5mm in diameter and the most stenosed area lumen area 
was 3.6 cm2 at its distal part (Fig. 3C). Syntax score was 22, 
whereas logistic Euroscore was 4.46%. The patient was advised 
to consider redo CABG vs PCI of the left main and LAD and 
had extensive discussions with both interventional cardiologist 
and cardiac surgeon. The patient finally opted for the PCI 
procedure, which was performed 3 days later.
FIGURE 1. Marked ST segment depression from V2 to V6 ECG leads with a significant drop of arterial blood pressure 97/60 mmHg 
took place during a treadmill stress test on the first minute of recovery.
PARTIALLY PROTECTED LEFT MAIN STENTING IN A PATIENT WITH COMPLETE OBSTRUCTION OF LEFT INTERNAL MAM-
MARY GRAFT
81
P C I  P R O C E D U R E
An EBU 3.5 6F guiding catheter was employed and the 
LAD and LCx were wired with BMW guidewires (Boston 
scientific). After predilating the lesion in the mid LAD (Riujin 
2.5x15 mm, 12 atm), a stent (Promus, Boston Scientific 3.0x20 
mm, 20 atm) was implanted with a very good result (Fig. 4A). 
Then another stent (Promus, Boston Scientific 3.5×28 mm, 
20 atm) was implanted at the proximal LAD in order to cover 
from the proximal part of the previous implanted stent, with a 
1mm overlapping area, to the ostium of the left main. The stent 
was inflated at 20 atm, while keeping the wire of the LCx jailed 
(Figure 4B). The result was very good but significant plaque 
shift towards the ostium of LCx occurred, causing a 70-80% 
stenosis with TIMI III flow. The LCx was re-wired with an 
ACS Whisper wire (Boston Scientific) and the ostial lesion was 
dilated with a balloon Riujin 3.0×15 mm resulting in a 10% 
residual stenosis. Then kissing ballooning was performed at 
the distal part of the left main using the prior Riujin 3x15mm 
balloon in the LAD and a new Riujin 2.0x15mm balloon in 
FIGURE 2. Coronary angiogram findings. A: Distal left main stenosis 60-70% extending in the proximal LAD, and a 70% stenosis at 
the mid LAD, B: A 50% stenosis at the proximal of LCx, C: Complete absence of left internal mammary artery (even after an infusion 
with a pigtail catheter in left subclavian artery) D: Patent radial graft anastomosed at the obtuse marginal.
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the LCx, both inflated up to 12 atm (Fig. 4C). The procedure 
was concluded with post-dilating with non compliant balloons 
both the distal stent (Durastar 3.0x10mm, 20 atm) including 
the overlapping region, and the stent at the left main (Durastar 
3.5x10mm, 20 atm), achieving a very good final result (Fig. 
4D) which was checked with a final IVUS run. Tirofiban 
was infused during and after the procedure. We applied a 
closure device (Angioseal) and the patient was sitting at his 
chair comfortably 3 hours later. His post-procedural course 
was uneventful, and the patient remained at the hospital one 
more day before being discharged.
D I S C U S S I O N
We present this case in order to emphasize mainly three 
issues that may arise in patients with an obstructed LIMA after 
CABG. Firstly, although usage of LIMA is an outstanding 
method of surgical revasularization, graft failure can occur 
and the size of the recipient vessel is a significant predictor 
of LIMA obstruction. Secondly, left main stenting in cases of 
LIMA obstruction represents a very good alternative, although 
many issues must be taken into account. Thirdly, IVUS can 
offer significant aid in cases of left main stenting.
The use of the LIMA graft and other arterial grafts has 
been an evolution in surgical revascularization in patients with 
coronary artery disease since LIMA has better long term pat-
ency rates as compared to saphenous vein grafts (SVGs). In 
the Veterans Affairs Cooperative Study Group1,2 patency at 10 
years was 61% for SVGs in 1,074 patients compared with 85% 
for LIMA grafts in 457 patients. If a vein graft was patent at 1 
week, the 6-year patency rate was 76% and the 10-year patency 
rate was 68%. On the other hand, if a LIMA graft was patent 
at 1 week, the 6-year and the 10-year patency rates were 90% 
and 88%, respectively. Thus, the 10-year patency of LIMA 
grafts was found to be better than SVGs. However, the 10-year 
patency for SVGs was found better and the 10-year patency for 
LIMA grafts worse than expected. This finding underlines the 
fact that although LIMA grafting is a very reliable and efficient 
technique of CABG, it does not ensure a 100% patency rate. 
It is known that vessel size is the “Achilles’ heel” of PCI, since 
it affects the outcome after coronary artery stenting with both 
bare metal stents and drug eluting stents (DES). The smaller 
the vessel the greater the restenosis rate both in bare metal3 
and DES4. However, it is noteworthy that in the latter study 
the best long-term predictors of graft patency were grafting 
into the LAD and grafting into a vessel that is >2.0 mm in 
diameter. In vessels >2.0 mm the 10-year patency was 88%, 
versus 55% in vessels with diameters <2.0 mm. For SVGs to 
the LAD, the 10-year patency was 90% for vessels >2.0 mm 
versus 52% for vessels <2.0 mm. For the LIMA, the 10-year 
patency was 100% for vessels >2.0 mm versus 82% for vessels 
<2.0 mm. Moreover in an older study5, it has been shown that 
the diameter of the recipient vessel by angiographic measure-
ment affects in-hospital mortality. It has been shown that vessel 
diameter is inversely associated with perioperative mortality 
related to CABG: 15.8% for 1.0-mm vessels, 4.6% for 1.5- to 
2.0-mm vessels, and 1.5% for 2.5- to 3.5-mm vessels. In the 
case we present the angiographic diameter of the mid LAD 
anastomosed with the LIMA was <2 mm and this might be 
the cause of LIMA obstruction 6 years after the initial CABG 
operation. Thus, from this point of view, the small size of the 
recipient vessel constitutes a real problem not only for PCI 
but also for CABG.
Regarding the management of this patient, it could not 
obviously be based only on medical therapy, because he had 
a significantly diseased partially protected left main and LAD 
associated with the development of hemodynamic instability 
during the treadmill stress test. In this case significant amount 
of myocardium was at risk and the prognosis was expected to 
be poor. Several observational studies6-8 initially demonstrated 
that patients with medically treated left main coronary artery 
FIGURE 3. IVUS run in LAD. A: At the mid part of LAD, the vessel was almost 3mm in diameter and the most stenosed area lumen 
was measured 2.4 cm2. B: At the ostial LAD the vessel was 3-3.5 mm in diameter and the lumen area was 3.3 cm2. C: Left main was 
almost 4-4.5mm in diameter and the most stenosed lumen area was 3.6 cm2 in its distal part.
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FIGURE 4. A: Stent implantation at mid LAD.B: Left main stenting. C: Kissing balloon inflation. D: Final result.
disease have 3-year survival rates of approximately 50%. Con-
trolled trials comparing CABG with medical therapy1,9,10 alone 
were initially performed in patients with stable angina and 
showed that surgical revascularization provided survival ben-
efit to patients with >50% left main stenosis. In the Coronary 
Artery Surgery study10, which included 1492 patients with left 
main disease, the 3-year survival rate was 91% for the surgical 
group and 69% for the medically-treated group. However, it 
should be reminded that in this cohort survival benefits were 
not observed in patients with mild-to-intermediate left main 
stenosis <60%, and normal left ventricular ejection fraction, 
since these patients had 3-year survival rate of >88%. From 
another point of view, this patient could be considered to be-
long in this group of patients, as the stenosis in the left main 
was angiographiaclly estimated to be around 60% and the 
ejection fraction of the left ventricle was normal. So it seems 
that the clinical “coin” has very often two faces. However, in 
all these studies the evaluation of the percentage of stenosed 
vessel lumen was based on quantitative coronary angiography, 
and not on IVUS data. It has been demonstrated and widely 
accepted that area lumen <4 cm2 for the LAD and <5.9cm2 
for the left main - just as in the present case- are considered 
cut off points that define significant stenosis and predict poor 
long term outcome.
Practice guidelines regarding managing of patients with 
either graft failure of a previous CABG or protected left main 
stenting have not been published. Accordingly, in cases like 
the one presented herein, decision making is based on clinical 
considerations and on extrapolations from other guidelines, as 
we have no evidence-based data. In the published guidelines 
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for the management of patients with stable angina by ACC/
AHA11, it is recommended that repeat CABG should be per-
formed in patients with multiple saphenous vein graft stenoses, 
with high-risk criteria on noninvasive testing, especially when 
there is significant stenosis of a graft supplying the LAD. PCI 
may be appropriate for focal saphenous vein graft lesions or 
multiple stenoses in poor candidates for reoperative surgery 
(class IIB, level of evidence C). Only one observational study 
presented data comparing medical and surgical treatment 
of patients with a history of CABG. That study showed that 
patients with late (>5 years after operation) stenoses in saphen-
ous vein grafts had a better survival rate with reoperation than 
initial medical management, particularly if a stenotic vein graft 
supplied the LAD12. Patients with early (<5 years after opera-
tion) stenoses in vein grafts did not appear to have a better 
survival rate with reoperation, although their symptom status 
improved. Patients with multiple vein grafts with late stenoses 
or late stenoses in an LAD vein graft should have reoperation 
in the absence of major contraindications to surgery. Despite 
improvement in the procedure-related complications of PCI 
for vein graft stenoses by the use of coronary stents, stenting 
has not significantly decreased the incidence of restenosis in 
vein grafts13 and is not an equivalent form of revascularization 
for patients with late vein-graft stenoses. The case we present 
is actually stenting of a partially protected left main, almost 
equivalent to diseased LAD with significant ostial stenosis. 
According to the guidelines for the management of patients 
with stable angina by ACC/AHA, PCI or CABG is recom-
mended for patients with one-vessel disease with significant 
proximal LAD (class IIA, level of evidence C). In our case 
CABG and PCI are clearly equivalent alternatives.
However, although this is a case of a partially protected left 
main it should be kept in mind that left main is always a chal-
lenging revascularization target and PCI may be associated 
with a lot of technical difficulties. Moreover, it seems to make 
sense that long term prognosis regarding target lesion (TLR) 
or target vessel revascularization (TVR) after PCI in the left 
main must be unaffected by its protection status. Significant 
left main coronary artery (LMCA) disease has been found in 
3% to 5% of all patients who undergo coronary angiography 
and in 10% to 30% of patients who undergo bypass surgery. 
Critical LMCA stenosis puts patients at high risk of cardiovas-
cular events because of the extent of jeopardized myocardium 
and concomitant multivessel coronary artery disease. Once 
CABG became the standard of care for left main disease, a dis-
tinction between “protected”—by at least 1 patent bypass graft 
to the left coronary artery—and “unprotected left main”— no 
patent bypass graft to the left coronary artery—was made. In 
the 1980s, early attempts at balloon angioplasty of unprotected 
left main stenoses were associated with poor early outcomes 
because of coronary dissection, abrupt closure, and restenosis. 
Mortality rates as high as 30% at 1 year were reported14-16 In 
the 1990s, bare metal stents were introduced and soon used to 
treat LMCA disease. Several small registries found a low rate 
of procedural complications, but the repeat revascularization 
rates of 20% to 30% because of restenosis were considered un-
acceptable17-19. Early bare metal stent registries for LMCA also 
found high mortality rates, particularly in high-risk patients, 
such as patients with acute coronary syndromes and poor left 
ventricular function. Importantly, high-risk subgroups often 
presented with late sudden death after stenting. In the early 
2000s, the introduction of drug-eluting stents (DES), with the 
promise of significantly reduced rates of restenosis20, raised 
the possibility of improved late outcomes in this challenging 
patient group.
Clinical outcomes after treatment of unprotected LMCA 
disease with either the sirolimus-eluting stent or the paclitaxel-
eluting stent from >20 small registries have been published. 
Results reported in these registries vary widely21-24. Cardiac 
mortality 6 to 12 months after the procedure ranges from 0% 
to 11%. Target lesion revascularization (TLR) or TVR rates 
range from 2% to 38%. This wide variation in clinical outcome 
appears largely because of variation in both patient selection 
and procedural technique. The first large-scale randomized 
comparison of CABG versus DES for unprotected LMCA 
was the SYNTAX25 (The SYNergy between percutaneous 
coronary intervention with TAXus and cardiac surgery) trial. 
This large trial contained a prespecified subgroup of 705 ran-
domized unprotected left main patients. At 1-year follow-up, 
the combined safety end point of death, myocardial infarction, 
and stroke was nonsignificantly higher in CABG patients (7% 
versus 9.2%; p=0.29). Although the repeat revascularization 
rate was statistically worse in stent patients (12% versus 6.7%; 
P=0.002), these differences were modest.
In the present case intravascular ultrasound examination 
helped us to choose the stents according to the most appropri-
ate dimension, and to decide about the strategy that we should 
follow for PCI in the left main artery. Since the conventional 
coronary angiogram is only a ‘lumenogram’ providing infor-
mation on lumen size but offering little insight into lesion or 
plaque characteristics, exact evaluation of LMCA disease is 
sometimes difficult because of peculiar anatomic and hemo-
dynamic factors such as large size, a short normal reference 
segment, overlapping of major vessels, streaming of contrast 
agent, and varied angulations. IVUS assessment before the 
procedure can not only detect significant stenosis but can 
also select the appropriate diameter and length of the stent 26. 
Additionally, IVUS can be very helpful in optimally expand-
ing the stent, with or without post-stent balloon dilatation to 
avoid under- or overstretch of the stent diameter27. Therefore, 
it seems that guidance by IVUS during LMCA stenting is 
of critical importance as compared with the use of IVUS in 
PCI treatment of other coronary lesions. It has been demon-
strated28 that elective stenting with IVUS guidance, especially 
in the case of drug-eluting stent placement, may reduce the 
long-term mortality rate for unprotected LMCA stenosis when 
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compared with conventional angiography guidance.
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